Literature DB >> 23116315

Chemical and structural features influencing the biological activity of curcumin.

K Indira Priyadarsini1.   

Abstract

Curcumin, a polyphenolic natural product, exhibits therapeutic activity against a number of diseases, attributed mainly to its chemical structure and unique physical, chemical, and biological properties. It is a diferuloyl methane molecule [1,7-bis (4-hydroxy-3- methoxyphenyl)-1,6-heptadiene-3,5-dione)] containing two ferulic acid residues joined by a methylene bridge. It has three important functionalities: an aromatic o-methoxy phenolic group, α, β-unsaturated β-diketo moiety and a seven carbon linker. Extensive research in the last two decades has provided evidence for the role of these different functional groups in its crucial biological activities. A few highlights of chemical structural features associated with the biological activity of curcumin are: The o-methoxyphenol group and methylenic hydrogen are responsible for the antioxidant activity of curcumin, and curcumin donates an electron/ hydrogen atom to reactive oxygen species. Curcumin interacts with a number of biomolecules through non-covalent and covalent binding. The hydrogen bonding and hydrophobicity of curcumin, arising from the aromatic and tautomeric structures along with the flexibility of the linker group are responsible for the non-covalent interactions. The α, β-unsaturated β-diketone moiety covalently interacts with protein thiols, through Michael reaction. The β-diketo group forms chelates with transition metals, there by reducing the metal induced toxicity and some of the metal complexes exhibit improved antioxidant activity as enzyme mimics. New analogues with improved activity are being developed with modifications on specific functional groups of curcumin. The physico-chemical and structural features associated with some of the biological activities of curcumin and important analogues are summarized in this article.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23116315     DOI: 10.2174/138161213805289228

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  34 in total

1.  Curcumin combined with glycyrrhetinic acid inhibits the development of hepatocellular carcinoma cells by down-regulating the PTEN/PI3K/AKT signalling pathway.

Authors:  Mingxiang Chang; Meimei Wu; Hanmin Li
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

2.  Chemistry: Chemical con artists foil drug discovery.

Authors:  Jonathan Baell; Michael A Walters
Journal:  Nature       Date:  2014-09-25       Impact factor: 49.962

3.  An integrated molecular modeling approach for the tryptase monomer-curcuminoid recognition analysis: conformational and bioenergetic features.

Authors:  Pathomwat Wongrattanakamon; Chadarat Ampasavate; Busaban Sirithunyalug; Supat Jiranusornkul
Journal:  J Bioenerg Biomembr       Date:  2018-11-10       Impact factor: 2.945

4.  Curcumin and hydroxamate-derivative (PCI-34058) interfere with histone deacetylase I catalytic core Asp-His charge relay system: atomistic simulation studies.

Authors:  I O Omotuyi; M O Abiodun; K Komolafe; O C Ejelonu; O Olusanya
Journal:  J Mol Model       Date:  2015-04-10       Impact factor: 1.810

Review 5.  Histone lysine specific demethylase 1 inhibitors.

Authors:  Samir Mehndiratta; Jing-Ping Liou
Journal:  RSC Med Chem       Date:  2020-07-31

Review 6.  Effects of Curcumin and Its Analogues on Infectious Diseases.

Authors:  Reza Ranjbar; Hossein Bagheri; Faezeh Ghasemi; Paul C Guest; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

7.  Considerations of Protein Subpockets in Fragment-Based Drug Design.

Authors:  Matthew Bartolowits; V Jo Davisson
Journal:  Chem Biol Drug Des       Date:  2015-08-31       Impact factor: 2.817

8.  Radical scavenger competition of alizarin and curcumin: a mechanistic DFT study on antioxidant activity.

Authors:  Malek Sadatsharifi; Mihály Purgel
Journal:  J Mol Model       Date:  2021-05-13       Impact factor: 1.810

9.  Curcumin inhibits proliferation of gastric cancer cells by impairing ATP-sensitive potassium channel opening.

Authors:  Xiaohong Liu; Kai Sun; Ailin Song; Xiaoyun Zhang; Xu Zhang; Xiaodong He
Journal:  World J Surg Oncol       Date:  2014-12-19       Impact factor: 2.754

Review 10.  Curcumin, a potent therapeutic nutraceutical and its enhanced delivery and bioaccessibility by pickering emulsions.

Authors:  Shima Saffarionpour; Levente L Diosady
Journal:  Drug Deliv Transl Res       Date:  2021-03-06       Impact factor: 4.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.